(Q24243452)

1

0 references

author name string

Denise Adams

2

0 references

Neil Brown

3

0 references

Jeffrey A Johnson

Cochrane Database of Systematic Reviews

4

0 references

publication date

23 April 2008

0 references

published in

0 references

cites work

Operating characteristics of a rank correlation test for publication bias

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007020

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007020

Update on cystic fibrosis epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007020

Advanced cystic fibrosis lung disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007020

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007020

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007020

Lung infections associated with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007020

Vitamin A supplementation for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007020

Interpretative strategies for lung function tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007020

Oxidative Stress in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007020

Oxidative stress in cystic fibrosis: dietary and metabolic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007020

7 January 2021

Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007020

7 January 2021

Antioxidant deficiency in cystic fibrosis: when is the right time to take action?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007020

7 January 2021

Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007020

7 January 2021

Oxidative stress and lung function

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007020

7 January 2021

8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007020

7 January 2021

In vivo lipid peroxidation and platelet activation in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007020

7 January 2021